Cointime

Matterhorn Biosciences

company

About

Matterhorn Biosciences is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule.

  • 1 - 10

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Matterhorn is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule. MR1 presents cancer-specific metabolites on the surface of cancer cells that are recognized and killed by T cells bearing a MR1-specific T cell receptor.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Matterhorn Biosciences has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2020 Series Unknown $30M 1 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Matterhorn Biosciences is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series Unknown
Cointime
เนื้อหา
บริษัท